Cargando…

Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors

AIM: Nuclear factor erythroid 2-related factor 2 (NRF2) is a key component in the cell’s response to oxidative and electrophilic stress and is a transcription factor regulating the expression of a collection of anti-oxidative and cytoprotective genes. Human epidermal growth factor receptor 4 (HER4/e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kankia, Ibrahim H., Paramasivan, Poornima, Elcombe, Matthew, Langdon, Simon P., Deeni, Yusuf Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400752/ https://www.ncbi.nlm.nih.gov/pubmed/36046141 http://dx.doi.org/10.37349/etat.2021.00040

Ejemplares similares

Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies
por: Paramasivan, Poornima, et al.
Publicado: (2019)

NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
por: Khalil, Hilal S., et al.
Publicado: (2016)

NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib
por: Kankia, Ibrahim H., et al.
Publicado: (2017)

A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
por: Khalil, Hilal S., et al.
Publicado: (2016)

Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation
por: Paramasivan, Poornima, et al.
Publicado: (2020)

Expression and localization of nuclear factor erythroid 2-related factor 2 in the ovarian tissues of mice at different ages
por: Sindan, Namita, et al.
Publicado: (2018)

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy
por: Goltsov, Alexey, et al.
Publicado: (2014)

Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
por: Cui, Wenpeng, et al.
Publicado: (2017)

Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
por: Smolková, Katarína, et al.
Publicado: (2020)

Prognostic Value and Immune Infiltration Analysis of Nuclear Factor Erythroid-2 Family Members in Ovarian Cancer
por: Dou, Rui, et al.
Publicado: (2022)

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
por: Spector, Neil, et al.
Publicado: (2007)

Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis
por: Vivarini, Áislan de Carvalho, et al.
Publicado: (2017)

Genomic Structure and Variation of Nuclear Factor (Erythroid-Derived 2)-Like 2
por: Cho, Hye-Youn
Publicado: (2013)

Biased activation of the receptor tyrosine kinase HER2
por: Catapano, Claudia, et al.
Publicado: (2023)

The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy
por: Kim, Ji Eun, et al.
Publicado: (2019)

Quinolinic Acid and Nuclear Factor Erythroid 2-Related Factor 2 in Depression: Role in Neuroprogression
por: Bansal, Yashika, et al.
Publicado: (2019)

Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
por: Seminotti, Bianca, et al.
Publicado: (2021)

Role of Nuclear Factor Erythroid 2‒Related Factor 2 in Chronic Obstructive Pulmonary Disease
por: Ban, Woo Ho, et al.
Publicado: (2022)

The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
por: Xia, Lei, et al.
Publicado: (2023)

Is Nuclear Factor Erythroid 2-Related Factor 2 a Target for the Intervention of Cytokine Storms?
por: Liu, Zihang, et al.
Publicado: (2023)

Expression of Nuclear Factor Erythroid 2 Protein in Malignant Cutaneous Tumors
por: Choi, Chang Yong, et al.
Publicado: (2014)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
por: Brand, Toni M., et al.
Publicado: (2013)

Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway
por: Li, Shengqiang, et al.
Publicado: (2021)

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2
por: Safari, Anahid, et al.
Publicado: (2019)

Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application
por: Qin, Yuhan, et al.
Publicado: (2022)

Molecular docking analysis of melamine with nuclear factor erythroid 2-related factor 2 and succinate dehydrogenase
por: Rai, Nitish, et al.
Publicado: (2022)

Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer
por: Kawasaki, Yota, et al.
Publicado: (2015)

Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) and Mitochondrial Dynamics/Mitophagy in Neurological Diseases
por: Kang, Tae-Cheon
Publicado: (2020)

The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review
por: Wang, Mingxuan, et al.
Publicado: (2020)

Comparative docking analysis of tyrosine kinase inhibitors with HER2 and HER4 receptors
por: Sonar, Priyanka, et al.
Publicado: (2022)

Lactobacillus delbrueckii Protected Intestinal Integrity, Alleviated Intestinal Oxidative Damage, and Activated Toll-Like Receptor–Bruton’s Tyrosine Kinase–Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Weaned Piglets Challenged with Lipopolysaccharide
por: Chen, Fengming, et al.
Publicado: (2021)

Retraction: Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Publicado: (2022)

Reducing toxic reactive carbonyl species in e-cigarette emissions: testing a harm-reduction strategy based on dicarbonyl trapping
por: de Falco, Bruna, et al.
Publicado: (2020)

Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways
por: Arnold, Philipp, et al.
Publicado: (2014)

Protective role of nuclear factor erythroid 2-related factor 2 in the hemorrhagic shock-induced inflammatory response
por: ZHAO, HAIGE, et al.
Publicado: (2016)

Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease
por: Ban, Woo Ho, et al.
Publicado: (2018)

Antioxidant mechanism of black garlic extract involving nuclear factor erythroid 2-like factor 2 pathway
por: Ha, Ae Wha, et al.
Publicado: (2017)

Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2
por: Chaparala, Anusha, et al.
Publicado: (2020)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_db2fisk33pkv01vqj5ahabe98c